YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Therapeutic Implications of TGF-β Pathway in Desmoid Tumor Based on Comprehensive Molecular Profiling and Clinicopathological Properties	CANCERS
2022	Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study	CLINICAL LUNG CANCER
2022	A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions	BLOOD ADVANCES
2022	Sex difference after acute myocardial infarction patients with a history of current smoking and long-term clinical outcomes: Results of KAMIR Registry	CARDIOLOGY JOURNAL
2022	Vegetation Size, Multiplicity, and Position in Patients With Infective Endocarditis	ANNALS OF THORACIC SURGERY
2022	Application of an Internet of Medical Things (IoMT) to Communications in a Hospital Environment	APPLIED SCIENCES-BASEL
2022	Corticosteroids and Mesalamine Versus Corticosteroids for Acute Severe Ulcerative Colitis: A Randomized Controlled Trial	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2022	A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy	Clinical Hypertension
2022	Bifurcation strategies using second-generation drug-eluting stents on clinical outcomes in diabetic patients	FRONTIERS IN CARDIOVASCULAR MEDICINE
2022	Successful Treatment of Vancomycin-Resistant Enterococcus species Bone and Joint Infection with Daptomycin Plus Beta Lactam Agents	INFECTION AND CHEMOTHERAPY
2022	Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society	Endocrinology and Metabolism(대한내분비학회지)
2022	Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study	LANCET ONCOLOGY
2022	Core Elements for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals	INFECTION AND CHEMOTHERAPY
2022	Blood Pressure Control in Patients with Diabetic Kidney Disease	Electrolytes & Blood Pressure
2022	C-reactive protein and statins in heart failure with reduced and preserved ejection fraction	FRONTIERS IN CARDIOVASCULAR MEDICINE
2022	A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11)	CLINICAL LUNG CANCER
2022	Paclitaxel-coated balloons for femoropopliteal peripheral arterial disease: final five-year results of the IN.PACT Global Study	EUROINTERVENTION
2022	Enhanced supportive care for advanced cancer patients: study protocol for a randomized controlled trial	BMC NURSING
2022	Relationship of Plaque Features at Coronary CT to Coronary Hemodynamics and Cardiovascular Events	RADIOLOGY
2022	Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy	THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY